Pedal Bcu, Llc
Clinical trials sponsored by Pedal Bcu, Llc, explained in plain language.
-
New hope for kids with relapsed leukemia: phase 3 trial launches
Disease control Recruiting nowThis study tests whether adding the drug venetoclax to standard chemotherapy helps children and young adults with relapsed acute myeloid leukemia (AML) live longer. About 130 participants aged 29 days to 21 years will be enrolled. The goal is to see if the combination improves su…
Phase: PHASE3 • Sponsor: PedAL BCU, LLC • Aim: Disease control
Last updated May 26, 2026 05:03 UTC
-
New hope for kids with stubborn leukemia: targeted drug combo enters first human tests
Disease control Recruiting nowThis early-phase trial tests a new drug called ziftomenib, which targets a specific genetic change in leukemia cells, combined with standard chemotherapy (FLA). It enrolls up to 20 children and young adults (ages 0–21) whose leukemia has come back or not responded to treatment. T…
Phase: PHASE1 • Sponsor: PedAL BCU, LLC • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
New hope for kids with tough leukemias: screening trial matches patients to targeted therapies
Knowledge-focused Recruiting nowThis study screens children and young adults (under 22) with leukemia that has returned or is difficult to treat. By analyzing their blood and bone marrow, doctors can identify specific genetic markers to match them with the most promising experimental treatments. The goal is to …
Phase: PHASE1, PHASE2 • Sponsor: PedAL BCU, LLC • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC